Evaluation of renal cancer progression in a mouse model of heart failure
- PMID: 34240830
- PMCID: PMC8360637
- DOI: 10.1002/cac2.12185
Evaluation of renal cancer progression in a mouse model of heart failure
Conflict of interest statement
The University Medical Center Groningen (UMCG), which employs the authors, has received research grants and/or fees from AstraZeneca, Abbott, Bristol‐Myers Squibb, Novartis, Novo Nordisk, and Roche. Dr. de Boer received speaker fees from Abbott, AstraZeneca, Bayer, Novartis, and Roche.
Figures

Similar articles
-
RENAL ARTERIOVENOUS FISTULA. A REVERSIBLE CAUSE OF HYPERTENSION AND HEART FAILURE.Am J Med. 1964 Oct;37:499-513. doi: 10.1016/0002-9343(64)90064-6. Am J Med. 1964. PMID: 14215839 No abstract available.
-
RENAL ARTERIOVENOUS FISTULA: OCCURRENCE IN RENAL CELL CARCINOMA.Am J Surg. 1964 Jul;108:82-4. doi: 10.1016/0002-9610(64)90085-6. Am J Surg. 1964. PMID: 14182444 No abstract available.
-
[Refractory cardiac failure as the presenting feature of a renal arteriovenous fistula and cancer of the kidney].Ann Med Interne (Paris). 1978 Mar;129(3):199-204. Ann Med Interne (Paris). 1978. PMID: 655518 French. No abstract available.
-
[Arteriovenous fistula with cardiac insufficiency disclosing kidney cancer].Rev Med Interne. 1996;17(4):329-32. doi: 10.1016/0248-8663(96)81438-x. Rev Med Interne. 1996. PMID: 8761798 Review. French.
-
Worsening renal function in heart failure: the need for a consensus definition.Int J Cardiol. 2014 Jul 1;174(3):484-91. doi: 10.1016/j.ijcard.2014.04.162. Epub 2014 Apr 21. Int J Cardiol. 2014. PMID: 24801076 Review.
Cited by
-
Cardiovascular Disease and Cancer: A Dangerous Liaison.Arterioscler Thromb Vasc Biol. 2025 Mar;45(3):359-371. doi: 10.1161/ATVBAHA.124.319863. Epub 2025 Jan 9. Arterioscler Thromb Vasc Biol. 2025. PMID: 39781742 Review.
-
Cardio-Oncology: Mechanisms, Drug Combinations, and Reverse Cardio-Oncology.Int J Mol Sci. 2022 Sep 13;23(18):10617. doi: 10.3390/ijms231810617. Int J Mol Sci. 2022. PMID: 36142538 Free PMC article. Review.
-
Update on preclinical models of cancer therapy-related cardiac dysfunction: Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio-Oncology, and the ESC Working Group on Cellular Biology of the Heart.Eur J Heart Fail. 2025 Jun;27(6):1028-1046. doi: 10.1002/ejhf.3636. Epub 2025 Mar 11. Eur J Heart Fail. 2025. PMID: 40069106 Free PMC article. Review.
-
Heart Failure Promotes Cancer Progression in an Integrin β1-Dependent Manner.Int J Mol Sci. 2023 Dec 11;24(24):17367. doi: 10.3390/ijms242417367. Int J Mol Sci. 2023. PMID: 38139195 Free PMC article.
-
Reverse cardio-oncology: Exploring the effects of cardiovascular disease on cancer pathogenesis.J Mol Cell Cardiol. 2022 Feb;163:1-8. doi: 10.1016/j.yjmcc.2021.09.008. Epub 2021 Sep 25. J Mol Cell Cardiol. 2022. PMID: 34582824 Free PMC article. Review.
References
-
- Meijers WC, Maglione M, Bakker SJL, Oberhuber R, Kieneker LM, de Jong S, et al. Heart failure stimulates tumor growth by circulating factors. Circulation. 2018;138(7):678–91. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical